Core Viewpoint - The A-share market shows positive momentum with the Shanghai Composite Index above the annual line, indicating a potential bullish trend in the market [1]. Group 1: Market Performance - As of 10:30 AM today, the Shanghai Composite Index is at 4112.37 points, with a gain of 0.72% [1]. - The total trading volume in the A-share market is 14,306.83 billion yuan [1]. Group 2: Stocks Breaking Annual Line - A total of 110 A-shares have surpassed the annual line today, with notable stocks including: - Zhongcheng Technology with a deviation rate of 12.46% and a price increase of 17.30% [1]. - Weining Health with a deviation rate of 10.62% and a price increase of 11.26% [1]. - Yaxin Security with a deviation rate of 8.21% and a price increase of 10.05% [1]. - Other stocks with smaller deviation rates that have just crossed the annual line include: - Fenghuang Optical, Jialiqi, and Jiechengtong [1].

来自交易信息汇总：1月8日主力资金净流入5048.34万元，呈现显著吸筹迹象。 交易信息汇总资金流向 1月8日主力资金净流入5048.34万元；游资资金净流出1341.38万元；散户资金净流出3706.96万元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2026年1月8日收盘，创业慧康(300451)报收于5.28元，上涨2.92%，换手率5.41%，成交量82.66万 手，成交额4.37亿元。 董秘最新回复 投资者： 公司是否储备脑机接口技术？ 董秘： 尊敬的投资者，您好！公司专注于医疗卫生健康信息化的建设、研发及服务创新，产品涵盖智 慧医疗、智慧卫生、医保、健康及养老等各种智慧场景。公司将持续关注新兴医疗健康应用场景的市场 机遇，若未来脑机接口等新应用场景在医疗行业逐步显现，公司将依托现有技术积累与战略发展规划， 及时跟进并积极探索拓展相关产品应用边界。感谢您的关注！ 当日关注点 ...

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Chuangyue Huikang (300451), indicating a significant decline in revenue and profit for the first three quarters of 2025 compared to the previous year [2] - As of January 8, 2026, Chuangyue Huikang's stock closed at 5.28 yuan, with a 2.92% increase, a turnover rate of 5.41%, and a trading volume of 826,600 hands, amounting to a total transaction value of 437 million yuan [1] - The company reported a main revenue of 862 million yuan for the first three quarters of 2025, a year-on-year decrease of 26.26%, and a net profit attributable to shareholders of -122 million yuan, a decline of 331.69% [2] Group 2 - In the third quarter of 2025, the company's single-quarter main revenue was 285 million yuan, down 35.5% year-on-year, with a net profit of -41.67 million yuan, reflecting a 264.2% decrease [2] - The company has shifted its main business focus from product development and sales to a broader range of services, including smart healthcare, internet medical services, medical IoT, and health city solutions [2] - Over the past 90 days, two institutions have rated the stock as a buy, with an average target price of 6.05 yuan [3]

Core Viewpoint - The company focuses on the construction, research and development, and service innovation of healthcare information technology, covering various smart scenarios in healthcare, health insurance, and elderly care [1] Group 1: Company Focus and Products - The company is dedicated to the development of smart healthcare, smart health, health insurance, and elderly care products [1] - The company will continue to monitor market opportunities in emerging healthcare applications [1] Group 2: Future Prospects - The company plans to leverage its existing technological accumulation and strategic development plans to explore and expand product applications in new areas, such as brain-computer interfaces, as they emerge in the healthcare industry [1]

Group 1 - The company is focused on the construction, research, and service innovation of health information technology, covering various smart scenarios such as smart healthcare, smart health, medical insurance, health, and elderly care [1] - The company will continue to monitor market opportunities in emerging healthcare applications and is open to exploring new applications like brain-computer interface technology if they become relevant in the medical industry [1] - The company emphasizes its commitment to leveraging existing technological accumulation and strategic development plans to timely follow up and actively explore the expansion of related product applications [1]

Core Viewpoint - The company is focused on the construction, research and development, and service innovation of health information technology, with a commitment to exploring emerging medical applications such as brain-computer interface technology in the future [2]. Group 1: Company Focus - The company specializes in smart healthcare, smart sanitation, medical insurance, health, and elderly care, covering various smart scenarios [2]. - The company will continue to monitor market opportunities in emerging medical health application scenarios [2]. Group 2: Future Exploration - If brain-computer interface technology and other new application scenarios gradually emerge in the medical industry, the company plans to leverage its existing technological accumulation and strategic development plans to actively explore and expand related product applications [2].

Core Viewpoint - The company, Chuangyue Huikang, is developing a comprehensive medical application service system centered around IoT technology, aiming to enhance healthcare services and operational management [2] Group 1: Company Developments - Chuangyue Huikang has established an intelligent IoT support platform that facilitates various medical application services, including convenience services, clinical application services, operational management services, and health services [2] - The company is creating IoT module products tailored to specific scenarios such as smart triage and appointment scheduling, with the goal of achieving comprehensive coverage of in-hospital medical scenarios [2] - The company commits to timely information disclosure regarding any business expansions in the future, encouraging stakeholders to pay attention to company announcements [2]

Group 1 - The core point of the news is that Chuangye Huikang's stock price increased by 5.17% to 5.09 CNY per share, with a trading volume of 211 million CNY and a turnover rate of 2.78%, resulting in a total market capitalization of 7.885 billion CNY [1] - Chuangye Huikang Technology Co., Ltd. is located in Hangzhou, Zhejiang Province, and was established on December 10, 1997. It was listed on May 14, 2015. The company specializes in the information technology construction of the healthcare industry, including software applications, system integration, and environmental monitoring services [1] - The main revenue composition of Chuangye Huikang includes: technical services (44.95%), software sales (44.48%), system integration (9.59%), and others (0.98%) [1] Group 2 - According to data from the top ten circulating shareholders of Chuangye Huikang, the Noan Fund holds a position in the company. The Noan Active Return Mixed A Fund (001706) reduced its holdings by 8.0292 million shares in the third quarter, now holding 16.108 million shares, which is 1.06% of the circulating shares [2] - The Noan Active Return Mixed A Fund was established on September 22, 2016, with a latest scale of 1.365 billion CNY. It has experienced a loss of 4.63% this year, ranking 8061 out of 8155 in its category, and has also lost 4.63% over the past year [2]

（编辑 姚尧） 证券日报网讯 12月29日，创业慧康在互动平台回答投资者提问时表示，数据资产的存储不在公司，在 医院客户本身，将来可以通过隐私计算和可信数据空间等技术，搭建价值变现的桥梁，目前公司正通过 将积累的医疗数据产品与AI技术深度融合，帮助客户推动数据资产从"存储"向"服务"与"智能"转变，从 而创造价值。公司利用高质量数据训练和优化AI模型，打造智能产品例如智能临床助手MedCopilot及关 键患者追踪系统APTS等，直接服务于医疗机构客户，实现数据价值的转化。公司亦积极参与国家数据 基础设施建设，构建可信数据生态，在合规前提下探索数据要素的流通与应用。请注意投资风险。 ...

Group 1 - The core point of the article is that Chuangyue Huikang (300451) has received a total of 24 million-level orders in the first three quarters of 2025 [1] Group 2 - The company encourages investors to pay attention to relevant announcements disclosed in designated media [1]